ECEzgi Can

Ezgi Can

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ezgi Can has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A myth: orthopedic implant pain in cold weather

    by Ahmet Acar, Ahmet Berkay Girgin, Ömer Torun, Ayşe Betül Acar, Ezgi Can, Muhammed Fazıl Özcan, Kadir Mullaoğlu, Evrim Duman

    Bone fractures are a common medical problem struggled by many people throughout their lives and are the most common cause of hospitalisation following trauma. In Australia there are 150000 hospital...

  • Open Access

    Impact of transforaminal epidural steroid injection on pain, disability, and kinesiophobia in lumbar disc herniation with radicular pain

    by Hande Ece Öz, Rumeysa Çeti̇nKaya Bulutoğlu, Furkan Çeti̇n, Ezgi̇ Can, Alp Eren Çelenli̇oĞlu, Ender Si̇r

    Background/aim: The aim was to evaluate the effect of single-level transforaminal epidural steroid injection (TFESI) on kinesiophobia (KP) in patients with lumbar radicular pain (RP) caused by single-root, single-level lumbar disc herniation (LDH). Materials and methods: A total of 63 patients diagnosed with unilateral single-level radicular pain due to LDH and treated with single-level TFESI were included. The Numeric Rating Scale (NRS), modified Oswestry Disability Index (MODI), Tampa Scale of Kinesiophobia (TSK), and Neuropathic pain (NP)-Douleur Neuropathique 4 Questionnaire (DN4) were used before the procedure and at 3 weeks and 3 months postoperatively. Results: At baseline, 76.19% (n = 48) of the patients exhibited KP. Significant improvements were observed in the NRS, TSK, MODI, and DN4 scores at both 3 weeks and 3 months (p < 0.001). Clinical outcomes were similar between the patients with and without KP, except for DN4 scores, which remained significantly higher in the KP group. A ≥50% reduction in the TSK score at the 3-month follow-up was positively correlated with ≥50% improvements in the NRS, MODI, and DN4 scores. Additionally, a longer symptom duration was negatively associated with the degree of improvement in the TSK. Conclusion: Our findings suggest that TFESI is an effective and safe method for alleviating pain and kinesiophobia in patients with chronic radicular pain due to LDH. Clinicians should be aware that a prolonged duration of symptoms is a risk factor that negatively influences the effectiveness of TFESI in cases of KP.

  • Open Access

    Turkish Validity and Reliability of Short Form McGill Pain Questionnaire-2 in Patients with Chronic Cervical Radicular Pain Due to Disc Herniation

    by Ezgi Can, Rumeysa Çetinkaya Bulutoğlu, Hande Ece Öz, Furkan Çetin, Alp Eren Çelenlioğlu, Ender Sir

    Background/Aims: This study aimed to evaluate the reliability and validity of the Turkish edition of the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) among chronic cervical radicular pain (CRRP) cases caused by disc herniation. The secondary aim was to assess the relationship between TR-SFMPQ-2 and other pain and disability scales. Materials and Methods: Data from 103 CRRP patients at the Algology outpatient clinic were analyzed. In addition to TR-SF-MPQ-2, the Numerical Rating Scale, Neck Disability Index, Quick Disabilities of the Arm, Shoulder, and Hand, Cervical Radiculopathy Impact Scale, and a 4-question neuropathic pain questionnaire were completed. Cronbach’s alpha (α) and ICC tests assessed reliability. Confirmatory factor and Spearman correlation analyses assessed validity. Results: Internal (α = 0.921) and test-retest reliability (ICC > 0.9, P < .001) were high across total and subscales (continuous, intermittent, neuropathic, emotional). TR-SF-MPQ-2 scores correlated with other scales (r = 0.404–0.648, P < .001). Confirmatory factor analysis supported a four-factor structure. Conclusion: TR-SF-MPQ-2 is valid and reliable for Turkish CRRP patients.


  • Open Access

    Ultrasound-guided continuous radiofrequency ablation of the proximal greater occipital nerve is effective in refractory occipital neuralgia: a retrospective cohort study

    by Suna Aşkın Turan, Şenay Aydın, Ezgi Can

    Pain in occipital neuralgia (ON) originates from the upper cervical nerves converging with the trigeminal complex. Greater occipital nerve (GON) blocks and radiofrequency treatments can be used in refractory ON.To assess the efficacy of ultrasound-guided proximal greater occipital nerve (PGON) continous radiofrequency ablation (CRFA) in ON throughout 1 year.We analyzed data from medical records and headache diaries. Before the intervention and 1, 3, 6, and 12 months after the intervention, at each appointment we evaluated the headache intensity through the 11-point Numeric Rating Scale (NRS-11), the headache disability, through the Six-Item Headache Impact Test (HIT-6), as well as the headache days per month. Treatment efficacy was determined by NRS-11 score < 4 at 12 months.A total of 18 patients were analyzed. The mean initial NRS-11 score was of 8.78 ± 0.732. At least 50% of pain reduction was noted in all patients at 6 months, and in 66% patients at 12 months. The frequency of attacks was correlated to poor response (r = 0.598; p = 0.009). The efficacy of the diagnostic block was correlated to successful response (r = -0.789; p = 0.001). For the categorical variables, the electric shock pain was associated with NRS-11 score ≥ 4 (p = 0.041), and lancinating pain was associated with NRS-11 score < 4 at 12 months (p = 0.031).Ultrasound-guided PGON CRFA in refractory ON significantly reduced pain for up to 1 year. The initial frequency of attacks, electric shock like pain, and reduced response to diagnostic block were associated with reduced response.


  • Open Access

    A Comparison of Transnasal Versus Ultrasound-Guided Suprazygomatic Approaches for Sphenopalatine Ganglion Blocks in Persistent Idiopathic Facial Pain

    by Ezgi Can, Ömer T Akkaya

    Background and Objectives: The majority of patients with persistent idiopathic facial pain (PIFP) do not respond to conservative treatment and thus require alternative therapeutic modalities. This study compared the effects of transnasal and ultrasound (US)-guided suprazygomatic approaches for sphenopalatine ganglion (SPG) block on pain management in refractory PIFP. Methods: This study included 38 patients with PIFP who underwent transnasal (Group T, n = 18) and US-guided suprazygomatic (Group U, n = 20) SPG block. Numeric Rating Scale (NRS) and Head Impact Test-6 (HIT-6) were used to assess therapeutic efficacy. Clinical evaluations were performed according to the scores recorded at baseline, 1 h, 1 week, and 4 weeks. Results: Transnasal and US-guided suprazygomatic SPG blocks in patients with PIFP provided effective and successful treatment results between groups at 1 h, 1 week, and 4 weeks compared to baseline ( P < 0.001). However, when NRS scores were compared at 1 h and 4 weeks, the US-guided suprazygomatic block provided significantly better pain relief ( P = 0.041 and P = 0.030, respectively). No adverse effects were observed, except transient facial paresthesia described in two patients in Group U. Conclusions: This retrospective study concluded that US-guided suprazygomatic SPG block can provide effective pain relief in PIFP patients at 4-week follow-up. This method can be regarded as an alternative treatment option, given that it is both safe and simple to apply.


  • Open Access

    Comparison of the Efficacy of Dorsal Root Ganglion Pulsed Radiofrequency for 2 Minutes versus 4 Minutes in the Treatment of Chronic Lumbosacral Radicular Pain

    by Gökhan Yıldız, Ezgi Can

    Objective: Pulsed radiofrequency treatment of the dorsal root ganglion has been increasingly used to treat lumbosacral radicular pain in recent decades. However, there is no consensus in the literature regarding issues such as pulsed radiofrequency application duration. This study aimed to determine the efficacy and incidence of adverse events between 2-minute and 4-minute pulsed radiofrequency for lumbosacral radicular pain. Material and Method: This retrospective study included 160 patients who underwent 2-minute or 4-minute dorsal root ganglion pulsed radiofrequency treatment (Group-2 minutes 82 patients and Group-4 minutes 78 patients). The Numeric Rating Scale and Oswestry Disability Index scores before, 1 and 6 months after the interventions were evaluated to assess the effectiveness of the procedures. The rate of intervention-related adverse events was determined for both durations. Results: Both the 2-minute and 4-minute procedures provided effective analgesia at 1 and 6 months compared with baseline. There was no difference in the pain scores between the two groups at the measurement times. At the 1-month follow-up, 50% or greater pain relief was achieved in 39% of patients in the 2-minute group compared to 50% in the 4-minute group, with no difference between the groups. There was no significant difference in the rate of procedure-related adverse events between the groups. Conclusion: Although a higher success rate was achieved with 4-minute pulsed radiofrequency, there was no significant difference, and both 2 and 4-minute pulsed radiofrequency procedures provided safe and effective analgesia compared with baseline. Prospective studies with larger sample sizes are needed.


  • Evaluation of the efficacy of ultrasound-guided selective cervical nerve root pulsed radiofrequency treatment in patients with chronic cervical radicular pain

    by Ezgi Can, Ömer Taylan Akkaya

    Purpose Management of cervical radicular pain is complex and may be resistant to conservative treatment. The primary aim of this study was to evaluate the efficacy of ultrasound-guided selective cervical nerve root pulsed radiofrequency (US-SCNR PRF) treatment in patients with radicular neck pain due to cervical disc herniation who did not respond to conservative treatment. The secondary aim was to determine the efficacy of the treatment in terms of functionality, neuropathic pain, and treatment-related adverse events. Methods This study included 62 patients with chronic cervical radicular pain who underwent US-SCNR PRF treatment. Pain intensity was assessed using the Numerical Rating Scale before treatment and at 1, 3, and 6 months after treatment. The Neck Disability Index and Douleur Neuropathique 4 Questions were used to assess functionality and neuropathic pain before and 6 months after treatment. Significant pain relief was defined as ≥ 50% reduction in the pain score compared with the pre-treatment score. Results Cervical radicular pain was significantly reduced at 1, 3, and 6 months after pulsed radiofrequency compared to pre-treatment (P < 0.001). Successful pain relief was achieved in 59.6% of the patients at 6 month. However, there was no significant difference between the mean pain scores in the 1st month, 3rd month and 6th month. In addition, the functionality and neuropathic pain scores were significantly reduced at 6 month. Conclusions These results suggest that US-SCNR PRF treatment is effective for cervical radicular pain, functionality, and neuropathic pain for at least six months in the majority of patients with refractory cervical radicular pain, and is considered a safer and preferable treatment modality due to real-time visualization of the cervical nerve roots and adjacent neurovascular structures and no radiation exposure.


  • Evaluation of the efficacy of ultrasound-guided maxillary and mandibular nerve pulsed radiofrequency treatment for trigeminal neuralgia and factors associated with successful response: a retrospective study

    by Ezgi Can, Gevher Rabia Genç Perdecioğlu, Gökhan Yıldız, Damla Yürük, Ömer Taylan Akkaya

    Background This study aimed to investigate the treatment efficacy and clinical and demographic characteristics affecting treatment success in patients who underwent ultrasound (US)-guided pulsed radiofrequency (PRF) to the maxillary and/or mandibular nerves for trigeminal neuralgia. Methods The data of patients with trigeminal neuralgia who underwent US-guided maxillary and/or mandibular nerve PRF between September 2022 and December 2023 were reviewed and the study was retrospectively designed. Good analgesia was defined as ≥ 50% reduction in pain score at 3 months after the procedure, and the demographic and clinical characteristics of the patients were assessed. Results Among the 72 included patients, 39 (54.2%) and 33 (45.8%) were classified as responders and non-responders, respectively. The age, pre- and post-procedural Numerical Rating Scale (NRS) scores, pain duration, and presence of constant pain were significantly lower in the responders. Logistic regression analysis revealed that older age (OR = 0.899, p < 0.001), high pre-procedural NRS scores (OR = 0.177, p = 0.009) and non-idiopathic (secondary or classic) etiology (OR = 0.062, p = 0.048) were significantly associated with an unsuccessful response to maxillary/mandibular PRF treatment. Conclusion This study is the first clinical trial to evaluate the efficacy of PRF therapy of the maxillary and mandibular nerves in the treatment of trigeminal neuralgia and demonstrated a significant reduction in pain scores at 3 months. Older age, high pre-procedural NRS scores, and non-idiopathic (secondary or classical) etiology are independent predictors of poor response to ultrasound-guided maxillary/mandibular nerve pulse radiofrequency treatment.


  • Comparison of tibial nerve pulsed radiofrequency and intralesional radiofrequency thermocoagulation in the treatment of painful calcaneal spur and plantar fasciitis: a randomized clinical trial

    by Gokhan Yildiz, Gevher Rabia Genc Perdecioglu, Damla Yuruk, Ezgi Can, Omer Taylan Akkaya

    Ultrasound-guided tibial nerve pulsed radiofrequency (US-guided TN PRF) and fluoroscopy-guided intralesional radiofrequency thermocoagulation (FL-guided intralesional RFT) adjacent to the painful calcaneal spur are two interventions for pain management in painful calcaneal spur and plantar fasciitis. This study aimed to compare the effectiveness of the two procedures. A prospective, randomized, single-blind study. Single-center pain clinic. Forty-nine patients who met the inclusion criteria were randomized into two groups. Group U (25 patients) received US-guided TN PRF at 42°C for 240 s, whereas Group F (24 patients) received FL-guided intralesional RFT at 80°C for 90 s. The most severe numeric rating scale (NRS) score during the first morning steps and the American Orthopedic Foot and Ankle Society (AOFAS) ankle-hindfoot scores were used to evaluate the effectiveness of the procedures. The study’s primary outcome assessed treatment effectiveness via the NRS, whereas the secondary outcomes included changes in the AOFAS score and the incidence of procedure-related mild adverse events. NRS and AOFAS scores significantly improved in Groups U and F at 1 and 3 months compared with baseline (P < .05), and there was no significant difference between the groups. At month 1, 50% or greater pain relief was achieved in 72% of patients in Group U and 75% of patients in Group F. No significant difference was observed in the incidence of mild adverse events between the groups. US-guided TN PRF and FL-guided intralesional RFT have shown significant effectiveness in the treatment of painful calcaneal spur and plantar fasciitis. Larger randomized controlled trials are needed. NCT06240507.